WHO ICTRP trial
Impact of Ondansetron on withdrawal syndrome and fentanyl requirement in opium…
IRCT2017051333940N1 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT2017051333940N1 |
|---|---|
| Public title | Impact of Ondansetron on withdrawal syndrome and fentanyl requirement in opium addicted patients under general anesthesia. |
| Scientific title | Impact of Ondansetron on withdrawal syndrome and fentanyl requirement in opium addicted patients under general anesthesia. |
| Primary sponsor | Pharmaceutical Research Center, Faculty of Pharmacy |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 2-3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Addicted patients with opioid dependence. Mental and behavioural disorders due to use of opioids;Mental and behavioural disorders due to use of opioids |
| Interventions | Intervention 1: Biography of included patients is registered and distributed in one of the study groups, and to each group of these patients, different doses of 4 mg and 8 mg of andestron are injected intravenously 15 minutes before… |
| Registration date | Jul 17, 2017 |
| Target size | 96 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: